Journal of Gastrointestinal Oncology

Edit Your Profile

Journal of Gastrointestinal Oncology Journal

publication venue for

Proton beam therapy for gastrointestinal cancers: Past, present, and future. 9:962-971. 2018
Pencil beam scanning versus passively scattered proton therapy for unresectable pancreatic cancer. 9:687-693. 2018
Does lymphocyte-to-monocyte ratio before, during, or after definitive chemoradiation for locally advanced pancreatic cancer predict for clinical outcomes?. 8:721-727. 2017
Favorable perioperative outcomes after resection of borderline resectable pancreatic cancer treated with neoadjuvant stereotactic radiation and chemotherapy compared with upfront pancreatectomy for resectable cancer. 7:547-555. 2016
Changes in neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios during chemoradiation predict for survival and pathologic complete response in trimodality esophageal cancer patients. 7:189-195. 2016
Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer. 7:221-227. 2016
Prognostic significance of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients treated with selective internal radiation therapy. 7:269-277. 2016
Pretreatment tumor volume as a prognostic factor in metastatic colorectal cancer treated with selective internal radiation to the liver using yttrium-90 resin microspheres. 7:931-937. 2016
Proton beam therapy for liver cancers 2020
Clinical outcomes and toxicities of proton radiotherapy for gastrointestinal neoplasms: a systematic review 2016
State-of-the-art molecular imaging in esophageal cancer management: Implications for diagnosis, prognosis, and treatment 2015
Adjuvant chemoradiation for pancreatic cancer: What does the evidence tell us? 2014

International Standard Serial Number (ISSN)

2078-6891

Electronic International Standard Serial Number (EISSN)

2219-679X